Authors: Garcia-Garrote, F Cercenado, E Martin-Pedroviejo, J Cuevas, O Bouza, E

Citation: F. Garcia-garrote et al., Comparative in vitro activity of the new quinolone gemifloxacin (SB-265805) with other fluoroquinolones against respiratory tract pathogens, J ANTIMICRO, 47(5), 2001, pp. 681-684

Authors: Cercenado, E Garcia-Garrote, F Bouza, E

Citation: E. Cercenado et al., In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates, J ANTIMICRO, 47(1), 2001, pp. 77-81

Authors: Garcia-Garrote, F Cercenado, E Bouza, E

Citation: F. Garcia-garrote et al., Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci, J CLIN MICR, 38(6), 2000, pp. 2108-2111

Authors: Alcala, L Cercenado, E Garcia-Garrote, F Bouza, E

Citation: L. Alcala et al., In vitro activity of the new quinolone moxifloxacin (Bay 12-8039) against resistant gram-positive clinical isolates, DIAG MICR I, 33(1), 1999, pp. 27-31

Authors: Bouza, E Garcia-Garrote, F Cercenado, E Marin, M Diaz, MS

Citation: E. Bouza et al., Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain, ANTIM AG CH, 43(4), 1999, pp. 981-982